//
Patrick Van Dreden
Petros Tzimas
ELEFTHERIA LEFKOU
Agathi Karakosta
Stellios Argyron
Evangelia Papapetrou
Despoina Pantazi
Alexandros Tselepis
Panagiota Stratigopoulou
Georgios Glantzounis
Kallirroi Kalantzi
Grigorios T. Gerotziafas
Hematology Laboratory, University Hospital of Ioannina, Greece, Ioannina, Greece
Atherothrombosis Research Centre/Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, Greece, Ionnina, Greece
INSERM U, Faculté de Médecine Pierre et Marie Curie, Université Paris VI, Paris, France
Service d'Hématologie Biologique Hôpital Tenon, Paris, France, Paris, France
Institut Universitaire de Cancérologie, Sorbonne University, Paris, France
Cancer biology and Therapeutics INSERM U, Faculté de Medecine Pierre et Marie Curie, Université Paris VI, Paris, France
Service d'Hématologie Clinique et de Thérapie Cellulaire, Saint Antoine Hospital, Paris, France
Department of Anaesthesia and Postoperative Intensive Care, Faculty of Medicine, University of Ioannina, Ioannina, Greece, Ioannina, Greece
Clinical Research department, Stago, Gennevilliers, France
HPB Unit, Department of Surgery, Faculty of Medicine, University of Ioannina, Greece, Ioannina, Greece
Research Group « Cancer, Haemostasis, Angiogenesis», Centre de recherche Saint-Antoine (CRSA), Sorbonne Université, Paris, France, Paris, French Guiana
Greece
France
United States
N/A
Oncology (ONC)
Solid malignancies
Prothrombin
D-dimer
Fibrinogen
Fibrinogen (IV)
Evithrom
FVIII
N/A
Observational
Prospective
NA
N/A
N/A
N/A